Strategic partnerships Wave Health recently partnered with Bayer AG to support data-driven, scalable care within NHS priorities. This indicates openness to collaboration with large pharma and healthcare organizations, presenting opportunities to offer integrated SaMD solutions and expand into large health systems and national programs via co-development or pilot programs.

Health system traction The platform targets chronic conditions across 220+ diseases, with a proven oncology PRO tracking app ranked highly. This breadth and proven performance in oncology suggest upsell potential to other long-term care departments, cancer centers, and integrated delivery networks seeking remote monitoring and proactive risk management.

Global conference presence Frequent ISPOR Europe, EMUC, and ASCO recognition and poster awards demonstrate active engagement with key clinical and health economics communities. This visibility helps validate the value proposition to hospital procurement teams and clinical stakeholders, aiding outreach for payer discussions and expanded deployments.

Clinical and economic impact The platform aims to reduce emergency visits and lower system costs through structured weekly symptom checks, which can be positioned to hospital finance leads as a tool for cost containment, readmission reduction, and capacity expansion within oncology, neurology, and chronic disease programs.

Scale-ready tech Technical stack includes cloud services, continuous delivery, and data-rich dashboards, signaling readiness for deep integrations with EHRs, patient apps, and care team workflows. This facilitates conversations with health systems, IT leaders, and system integrators about seamless deployments and security/compliance alignment.